Making Prescription Drugs More Affordable Under the Biden Administration

This Viewpoint discusses policies the Biden administration can enact to reduce costs, including benchmarking Medicare Part B drug payments to the lowest price paid in similar countries, preventing Part D plans from negotiating confidential rebates with manufacturers, and patent reform to promote generic drug use.
Source: JAMA - Category: General Medicine Source Type: research